PET/MRI and Novel Targets for Breast Cancer

HW Chung, KS Park, I Lim, WC Noh, YB Yoo, SE Nam… - Biomedicines, 2024 - mdpi.com
Breast cancer, with its global prevalence and impact on women's health, necessitates
effective early detection and accurate staging for optimal patient outcomes. Traditional …

Clinical applications of fibroblast activation protein‐targeted theranostics in oncologic and nononcologic disease: Current status and future directions

H Fu, W Guo, J Huang, H Wu, H Chen - iRADIOLOGY, 2023 - Wiley Online Library
Quinoline‐based fibroblast activation protein (FAP) inhibitor (FAPI)‐based positron emission
tomography (PET) imaging and radioligand therapy (RLT) are being investigated for use in a …

[68Ga] Ga-FAPI-46 False-Positive Uptake After Chemotherapy in Nonseminomatous Germ Cell Tumor Metastatic Lesions

V Ludwig, PG Maliha, J Shen, D Tonnelet… - Journal of Nuclear …, 2024 - Soc Nuclear Med
A38-y-old man with mixed, nonseminomatous germ cell carcinoma metastatic to the lung,
liver, and retroperitoneal lymph nodes was treated with left orchiectomy and 4 cycles of …

A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma

C Guo, Y Liu, H Yang, Y Xia, X Li, L Chen… - British Journal of …, 2024 - academic.oup.com
Objectives As a promising positron emission tomography (PET) tracer,[68Ga] Ga-fibroblast
activation protein inhibitor-04 ([68Ga] Ga-FAPI-04) performs better than 2-[18F] fluoro-2 …

FAPI 成像: 突破传统PET/CT 在癌症诊断中的局限性

董欣, 孙瑶, 汪菲, 张术, 谢国柱 - 分子影像学杂志, 2024 - j-fzyx.com
近年来, 传统的18 F-氟代脱氧葡萄糖PET/CT 在癌症诊断中得到广泛应用,
但其在检测微小转移和淋巴结转移及显像特异性方面存在一定局限性. 成纤维细胞激活蛋白α …

[DOC][DOC] SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET

TA Hope, J Calais, AH Goenka, U Haberkorn… - rdcms-snmmi.s3.amazonaws.com
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international
scientific and professional organization founded in 1954 to promote the science, technology …